CABA smart money
Cabaletta Bio, INC. (CABA): 3 insider buys, 3 top funds holding it, 1 ETF change in the public filings.
Insider buys, 12 months$201k
Insider buys
| Filed | Who | Role | Amount | Price |
|---|---|---|---|---|
| 2026-01-21 | Nichtberger Steven | President & CEO | $101k | $2.24 |
| 2026-01-21 | Gavel Steve | Chief Commercial Officer | $50k | $2.27 |
| 2026-01-21 | Tomasello Shawn | Director | $50k | $2.21 |
Top 100 funds holding it
| # | Fund | Change | Weight | Value |
|---|---|---|---|---|
| 58 | Bain Capital Life Sciences Investors, LLC | ADD +23% | 2.73% | $41M |
| 72 | Sphera Funds Management LTD. | TRIM -5% | 0.37% | $2M |
| 86 | Adar1 Capital Management, LLC | TRIM -20% | 0.00% | $100k |
ETF changes
| ETF | Change | Value | Report |
|---|---|---|---|
| State Street(R) Spdr(R) S&p(R) Biotech ETF | BUY | +$16M | 2026-06-30 |